Adjuvant high-dose-rate brachytherapy for recurrent orbital solitary fibrous tumour: case report and review of the literature

Key Points

• Significant tumor reduction observed post-brachytherapy, indicating effective intervention.
• The patient showed improved clinical outcomes two months after treatment, with a notable decrease in tumor size.
• Retrospective analysis included literature review and case examination highlighting the treatment's efficacy.
• Results suggest high-dose-rate brachytherapy effectively targets orbital tumors, warranting further investigation.